Chen Liang, Li Jian-xing, Huang Xiao-bo, Wang Xiao-feng
Department of Urology, Peking University People's Hospital, Beijing 100044, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2014 Aug 18;46(4):566-9.
To investigate the risk factors of systemic inflammatory response syndrome (SIRS) after one-phase treatment for apyrexic calculous pyonephrosis by percutaneous nephrolithotomy (PCNL).
Clinical data of consecutive apyrexic calculous pyonephrosis patients who underwent one-stage PCNL from January 2008 to December 2013 were analyzed retrospectively. The data collected included white blood cells in urine analysis before surgery, midstream urine culture, preoperative renal function, using antibiotics time before surgery, operative time, the number of tracts, intraoperative irrigation peak flow, blood transfusion, and stone composition. Chi-square, t test and Logistic regression methods were used for analysis of each factor and SIRS.
A total of 182 patients were enrolled in this study and 38 patients developed SIRS (20.88%). There were no statistically significant differences among white blood cells in urine analysis (P = 0.483), urine culture positive (P = 0.136), and struvite (P = 0.324) in terms of the incidence of postoperative SIRS. Multivariate Logistic regression model indicated that risk factors of SIRS for apyrexic calculous pyonephrosis after one-phase PCNL were renal insufficiency (OR = 5.41, 95% CI 1.84 to 22.64, P = 0.014), operative time (OR = 1.01, 95% CI 1.00 to 1.02, P = 0.024), operative tracts (OR = 3.37, 95% CI -1.92 to 32.55, P = 0.077), intraoperative irrigation peak flow ≥500 mL/min (OR = 45.87,95% CI 4.39 to 231.68, P = 0.007), and blood transfusion (OR = 5.98, 95% CI 1.12 to 46.66, P = 0.043). The protective factor was antibiotics use for more than 3 days (OR = 0.34, 95% CI -3.92 to 12.55, P = 0.047).
The incidence of SIRS after one-phase PCNL treatment for apyrexic calculous pyonephrosis was similar to that of other patients. It is relatively safe and reliable to do this. Preoperative antibiotics should be used for more than 3 days before surgery. Careful manipulation is needed to avoid blood transfusion. It is better to shorten the operative time and to reduce multiple tracts operation. Particularly, irrigation peak flow ≥500 mL/min should be avoided in the circumstance of bleeding or turbid urine.
探讨经皮肾镜取石术(PCNL)一期治疗无发热性结石性脓肾后发生全身炎症反应综合征(SIRS)的危险因素。
回顾性分析2008年1月至2013年12月期间连续接受一期PCNL治疗的无发热性结石性脓肾患者的临床资料。收集的数据包括术前尿液分析中的白细胞、中段尿培养、术前肾功能、术前使用抗生素的时间、手术时间、通道数量、术中冲洗峰值流量、输血情况以及结石成分。采用卡方检验、t检验和Logistic回归方法分析各因素与SIRS的关系。
本研究共纳入182例患者,其中38例发生SIRS(20.88%)。术后SIRS发生率在尿液分析白细胞(P = 0.483)、尿培养阳性(P = 0.136)和鸟粪石(P = 0.324)方面无统计学显著差异。多因素Logistic回归模型表明,一期PCNL治疗无发热性结石性脓肾后发生SIRS的危险因素为肾功能不全(OR = 5.41,95%CI 1.84至22.64,P = 0.014)、手术时间(OR = 1.01,95%CI 1.00至1.02,P = 0.024)、手术通道(OR = 3.37,95%CI -1.92至32.55,P = 0.077)、术中冲洗峰值流量≥500 mL/min(OR = 45.87,95%CI 4.39至231.68,P = 0.007)和输血(OR = 5.98,95%CI 1.12至46.66,P = 0.043)。保护因素为使用抗生素超过3天(OR = 0.34,95%CI -3.92至12.55,P = 0.047)。
一期PCNL治疗无发热性结石性脓肾后SIRS的发生率与其他患者相似。该治疗方法相对安全可靠。术前应使用抗生素超过3天。需谨慎操作以避免输血。最好缩短手术时间并减少多通道手术。特别是在出血或尿液浑浊的情况下,应避免冲洗峰值流量≥500 mL/min。